Avianas SARS-CoV-2 Diagnostic: Identifying Acute Viral Infection and Viral Load: A Novel Technology with Potential for the Warfighter
[Technical Report, Briefing Charts]
AIR FORCE MEDICAL WING (59TH) LACKLAND AFB TXAVIANA MOLECULAR TECHNOLOGIES LLC ORLANDO FL
Pagination or Media Count:
SARS-CoV-2 has devastated the health of millions of people worldwide and while this pandemic has stimulated many innovations in testing, none can detect the actual infectious virions but rely on RNA or protein detection. Aviana AMT has developed a surface acoustic wave based SAW innovative, fast 10min, potentially cost-effective, and point of care POC platform that can detect infectious virions of SARS-CoV-2. AMTs sensors are based on radiofrequency-based chips which detect mass changes bound to the chip surface the chosen chip is ideal for detection of whole virus. We present initial data on detection of SARS-CoV-2 virus using our Pegasus Digital Biosensing Platform DBP utilizing our RF chips.
- Medicine and Medical Research
- Medical Facilities, Equipment and Supplies